NASDAQ · KIDS
Healthcare · Medical - Devices
$22.41
Down-$0.18 (-0.80%)
Updated Sep 8, 2026, 1:25 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
KIDS closed at $22.41 after 20 trading sessions, down 3.74% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $22.29 | $22.56 | $21.93 | $22.41 | 129.51K |
| Sep 3, 2026 | $23.05 | $23.18 | $22.10 | $22.59 | 148.27K |
| Sep 2, 2026 | $23.03 | $23.75 | $22.74 | $22.80 | 202.89K |
| Sep 1, 2026 | $23.38 | $23.80 | $22.84 | $23.00 | 139.8K |
| Aug 31, 2026 | $23.42 | $23.66 | $22.84 | $23.31 | 130.09K |
| Aug 28, 2026 | $23.35 | $23.89 | $23.00 | $23.65 | 487.05K |
| Aug 27, 2026 | $23.79 | $23.92 | $23.19 | $23.32 | 300.39K |
| Aug 26, 2026 | $24.33 | $24.91 | $24.00 | $24.03 | 169.61K |
| Aug 25, 2026 | $24.99 | $25.26 | $24.30 | $24.50 | 188.07K |
| Aug 24, 2026 | $25.65 | $26.3907 | $25.00 | $25.07 | 324.51K |
| Aug 21, 2026 | $26.23 | $26.23 | $25.23 | $25.65 | 364.62K |
| Aug 20, 2026 | $26.22 | $26.74 | $26.04 | $26.23 | 259.62K |
| Aug 19, 2026 | $25.775 | $26.71 | $25.61 | $26.50 | 378.01K |
| Aug 18, 2026 | $24.71 | $25.57 | $24.325 | $25.50 | 206.28K |
| Aug 17, 2026 | $24.75 | $25.155 | $24.37 | $24.70 | 177.33K |
| Aug 14, 2026 | $25.01 | $25.35 | $24.73 | $24.80 | 132.78K |
| Aug 13, 2026 | $25.00 | $25.24 | $24.55 | $25.01 | 205.63K |
| Aug 12, 2026 | $24.33 | $25.01 | $23.995 | $24.86 | 247.54K |
| Aug 11, 2026 | $23.30 | $24.56 | $23.065 | $24.24 | 231.37K |
| Aug 10, 2026 | $22.75 | $23.42 | $22.75 | $23.28 | 258.52K |
The latest Smart Investors Daily articles mentioning KIDS.
KIDS research
Company profile and research snapshot.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 20, 2026 | BTIG | Buy | — |
| Aug 5, 2026 | Needham | Buy | — |
| Aug 5, 2026 | Piper Sandler | Overweight | — |
| Jul 16, 2026 | Truist Securities | Hold | — |
| May 1, 2026 | BTIG | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 25, 2026
Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System
Benzinga · Aug 20, 2026
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $24 to $29.
Yahoo · Aug 12, 2026
Trauma and deformity revenue surged 26% as adjusted EBITDA hit record $6.8 million.
Yahoo · Aug 5, 2026
Moby summary of OrthoPediatrics Corp.'s Q2 2026 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning KIDS.
